Literature DB >> 16842971

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

Frank Jessen1, Harald Scherk, Frank Träber, Sonja Theyson, Julia Berning, Ralf Tepest, Peter Falkai, Hans-H Schild, Wolfgang Maier, Michael Wagner, Wolfgang Block.   

Abstract

We used proton magnetic resonance spectroscopy (1H MRS) to examine biochemical characteristics of the brain tissue in subjects at risk for schizophrenia. Nineteen participants fulfilling research criteria for an early (n=10) or a late (n=9) at-risk syndrome, 21 patients with full disease according to DSM IV and 31 healthy control subjects were included in the study. Single-voxel 1H MRS was performed in the left frontal lobe, the anterior cingulate gyrus and the left superior temporal lobe. Subjects were followed longitudinally to detect conversion to schizophrenia. We observed a significant reduction of the metabolic ratios NAA/Cr and NAA/Cho in the left frontal lobe and of NAA/Cr in the anterior cingulate gyrus in both at-risk groups and in the schizophrenic patients compared with healthy controls. Those at-risk subjects, who converted to schizophrenia within the observation period, had a higher Cho/Cr and a lower NAA/Cho ratio in the anterior cingulate gyrus compared with non-converters. NAA/Cr did not differ between converters and non-converters. Six at-risk subjects were taking antidepressants, two were taking antipsychotics. There was no difference in any metabolic ratio in any region between at-risk subjects with and without medication. We conclude that the reduction of the neuronal marker NAA in the left prefrontal lobe and the anterior cingulate gyrus may represent a vulnerability indicator for schizophrenia in at-risk subjects, while elevated Cho in the anterior cingulate gyrus may be a predictor for conversion from the prodromal state to the full disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842971     DOI: 10.1016/j.schres.2006.06.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

1.  Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Authors:  Tatsunobu Natsubori; Hideyuki Inoue; Osamu Abe; Yosuke Takano; Norichika Iwashiro; Yuta Aoki; Shinsuke Koike; Noriaki Yahata; Masaki Katsura; Wataru Gonoi; Hiroki Sasaki; Hidemasa Takao; Kiyoto Kasai; Hidenori Yamasue
Journal:  Schizophr Bull       Date:  2013-09-10       Impact factor: 9.306

Review 2.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

3.  Impaired context processing as a potential marker of psychosis risk state.

Authors:  Tara A Niendam; Tyler A Lesh; Jong Yoon; Andrew J Westphal; Natalie Hutchison; J Daniel Ragland; Marjorie Solomon; Michael Minzenberg; Cameron S Carter
Journal:  Psychiatry Res       Date:  2013-10-11       Impact factor: 3.222

4.  Magnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands.

Authors:  Aristides A Capizzano; Juana L Nicoll Toscano; Beng-Choon Ho
Journal:  Schizophr Res       Date:  2011-06-25       Impact factor: 4.939

5.  N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.

Authors:  Frank Jessen; Natascha Fingerhut; Alois M Sprinkart; Kai-Uwe Kühn; Nadine Petrovsky; Wolfgang Maier; Hans-H Schild; Wolfgang Block; Michael Wagner; Frank Träber
Journal:  Schizophr Bull       Date:  2011-09-12       Impact factor: 9.306

Review 6.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

7.  Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study.

Authors:  Min Soo Byun; Jung-Seok Choi; So Young Yoo; Do-Hyung Kang; Chi-Hoon Choi; Dong Pyo Jang; Wi Hoon Jung; Myung Hun Jung; Joon Hwan Jang; Jong-Min Lee; Jun Soo Kwon
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

Review 8.  Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions.

Authors:  Wi Hoon Jung; Joon Hwan Jang; Min Soo Byun; Suk Kyoon An; Jun Soo Kwon
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

9.  5-HT2A receptor density is decreased in the at-risk mental state.

Authors:  René Hurlemann; Andreas Matusch; Kai-Uwe Kuhn; Julia Berning; David Elmenhorst; Oliver Winz; Heike Kolsch; Karl Zilles; Michael Wagner; Wolfgang Maier; Andreas Bauer
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

10.  Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder.

Authors:  Fernando Sarramea Crespo; Rogelio Luque; David Prieto; Pablo Sau; Carmen Albert; Itziar Leal; Ana de Luxan; Maria Isabel Osuna; Miguel Ruiz; Rosa Galán; Francisco Cabaleiro; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.